Olopatadine Hydrochloride (Aurobindo Pharma Limited)
Welcome to the PulseAid listing for the Olopatadine Hydrochloride drug offered from Aurobindo Pharma Limited. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Aurobindo Pharma Limited |
| NON-PROPRIETARY NAME: | Olopatadine Hydrochloride |
| SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-12-18 |
| END MARKETING DATE: | 0000-00-00 |
Olopatadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olopatadine Hydrochloride from Aurobindo Pharma Limited |
| LABELER NAME: | Aurobindo Pharma Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2015-12-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65862-757_95ece6ad-1aba-4c61-9459-b00b9861d3d4 |
| PRODUCT NDC: | 65862-757 |
| APPLICATION NUMBER: | ANDA204812 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
